0 likes | 11 Views
Experience a groundbreaking development in patient care with Selpercatinib, now offered at Impomed Healthcare. This innovative solution represents a major advancement in personalized medicine, providing improved treatment choices for patients. Selpercatinib, an advanced therapeutic option, showcases outstanding effectiveness in addressing particular genetic mutations, guaranteeing accuracy and efficiency. Enhance the level of care with Impomed Healthcare's dedication to delivering creative solutions that enable superior results and enhanced quality of life for patients. Embrace the healthcare
E N D
SELPERCATINIB Home | Cancer | Solid Tumors | SELPERCATINIB SELPERCATINIB Capsules Description Composition Dosage Indications "RETEVMO (selpercatinib) is a kinase inhibitor. RETEVMO (selpercatinib) is supplied as 40 mg or 80 mg hard gelatin capsules for oral use. Each capsule contains inactive ingredients of microcrystalline cellulose and colloidal silicon dioxide. The 40 mg capsule shell is composed of gelatin, titanium dioxide, ferric oxide black and black ink. The 80 mg capsule shell is composed of gelatin, titanium dioxide, FD&C blue #1 and black ink. The black ink is composed of shellac, potassium hydroxide and ferric oxide black. " Copyright © 2024 ImpoMed Convert web pages and HTML files to PDF in your applications with the Pdfcrowd HTML to PDF API Printed with Pdfcrowd.com